Monkeypox
Children at high risk for monkeypox complications, review finds
Children aged younger than 8 years are at an elevated risk for monkeypox complications and should be considered a high-risk group, according to a review article published in The Pediatric Infectious Disease Journal.
Monkeypox worse for those with weakened immune systems, HIV, new data show
Although the number of new monkeypox cases has slowed in recent weeks, new data published Wednesday show people with weakened immune systems, especially those with HIV, are at risk for severe disease.
VIDEO: Should ACAM2000 be a first-line monkeypox vaccine? Two experts debate
WASHINGTON — Should ACAM2000 be a first-line vaccine in the current monkeypox outbreak? That was the topic of a pro/con debate during a “clinical controversies” session at IDWeek.
VIDEO: Incoming IDSA President Carlos del Rio, MD, lays out agenda for next year
WASHINGTON — Carlos del Rio, MD, an Infectious Disease News Editorial Board Member and the new president of the Infectious Diseases Society of America, discussed his agenda with Healio.
Q&A: Monkeypox added to dermatology registry to track cutaneous manifestations of disease
When WHO declared the global monkeypox outbreak a public health emergency in July, the American Academy of Dermatology and International League of Dermatological Societies added a new monkeypox registry to the existing COVID-19 dermatology registry.
Accidental needlestick makes Florida nurse first case of occupationally acquired monkeypox
A Florida nurse has developed monkeypox infection after an accidental needlestick exposure in the first case of occupationally acquired monkeypox during the U.S. outbreak, according to health officials.
FDA authorizes Abbott’s monkeypox PCR test for emergency use
The FDA has issued an emergency use authorization to Abbott Molecular for its real-time PCR test for monkeypox using lesion swab specimens from those with suspected virus infection.
HHS expands pool of providers who can administer monkeypox vaccine
HHS Secretary Xavier Becerra has amended the Public Readiness and Emergency Preparedness Act declaration, expanding the pool of providers authorized to administer vaccines against smallpox and monkeypox.
Clinical trial of antiviral for monkeypox goes forward as cases decline
Experts involved with an NIH trial of tecovirimat said that even as cases of monkeypox continue to decline nationally, it is important to establish whether the antiviral is effective against the infection.
Monkeypox should be considered in high-risk populations with neurologic symptoms
Monkeypox should be considered in high-risk populations who present with neurologic symptoms, warranting the need for serology and PCR testing of blood and spinal fluid, researchers wrote in JAMA Neurology.